Cisplatin combination chemotherapy in advanced seminoma
β Scribed by Giorgio Pizzocaro; Roberto Salvioni; Luigi Piva; Fulvio Zanoni; Angelo Milani; Marco Faustini
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 532 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twenty-nine patients with advanced refractory breast cancer were treated with cisplatin 20 mg/m2/d and VP-16 100 mg/d for 5 days every 3 4 weeks. Ten patients received mitomycin C 10 mg/m2 every 6 weeks additionally. Partial response was obtained in 10 of 26 evaluable patients (38%). The response ra
## Background: The efficacy of cisplatinum combined chemotherapy modalities was investigated in a variety of trials for patients with advanced seminoma. results regarding remission rates and survival are encouraging. ## Methods: Between december 1981 and january 1994, 13 patients with either rela